Ranolazine in ALS: safety, and effect on cramps, function and quality of life.
The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS.
Study ID: 4587
NCT Number: NCT06527222
Principal Investigator: William Arnold, MD
Department: Health Affairs
Eligibility: Both men and women 18 years old to 100 years old. Does not accept healthy volunteers.
For questions about this study, please contact:
ClinicalTrialsInterest@health.missouri.edu(573) 882-7026